DocMorris (Switzerland) Analysis
| DOCM Stock | 4.09 0.08 2.00% |
200 Day MA 6.1235 | 50 Day MA 5.4162 | Beta 1.808 |
Macro event markers
DocMorris AG is currently estimated as overvalued with a Real Value of $3.94. A key objective of stock analysis is establishing intrinsic value context. The framework estimates DocMorris' value using fundamental inputs rather than market price alone. This approach pairs balance-sheet fundamentals with chart-based technical analysis. Each analytical method adds a distinct perspective on value and price action.
Over the last reporting cycle, Net Debt is aligned with a developing negatively pattern. For the prior annual period, Net Debt came in at 249.36 Million. As of the most recent trading session, Long Term Debt Total is projected to grow to approximately 347.6 M, whereas Short and Long Term Debt Total is moving lower toward slightly above 217.3 M. Higher leverage ratios can signal increased financial risk for DocMorris. Debt service obligations can constrain earnings growth over time. Values are derived from reported financial statements. All content is derived from available inputs and carries no advisory implication. Debt Ratio | First Reported 2010-12-31 | Previous Quarter 0.36 | Current Value 0.22 | Quarterly Volatility 0.12736804 |
Macro event markers
DocMorris AG (DOCM.SW) recorded an improvement of $32.5 million in Net Income, a net loss of $97.3 million, and a net loss attributable to common shareholders of $91.9 million.
Please check Interest Expense and Depreciation And Amortization for complete statement details.
DocMorris |
Stock Analysis Notes
About 19.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.42. Some equities with similar Price to Book (P/B) outperform the market in the long run. DocMorris AG recorded a loss per share of 4.58. The company had its last dividend issued on the 22nd of November 2018. The firm completed a 593:292 stock split on 13th of May 2025. DocMorris AG (DOCM.SW) recorded $0.60 in Intangibles To Total Assets, $778.1 million in Total Assets, and a Return On Assets of -14.0%.Book Value Per Share | 14.48 |
Investor Insights and Alerts
| DocMorris AG generated a negative expected return over the last 90 days | |
| DocMorris AG has high historical volatility and very poor performance | |
| DocMorris AG has high likelihood to experience some financial distress in the next 2 years | |
| The company reported revenue of 1.02 B. Net Loss for the year was -97.25 M with profit before overhead, payroll, taxes, and interest of 230.27 M. | |
| DocMorris AG has accumulated about 95.37 M in cash with -26.6 M of positive cash flow from operations. | |
| Roughly 19.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Doc Morris Overhauls Board to Strengthen Digital Health and Governance Expertise - Tip Ranks |
Market Capitalization
DocMorris AG is currently valued at 194.98 M by market capitalization, putting the company in the small-cap cohort across consumer staples distribution & retail companies. Additional sizing evidence includes about 48.6 M shares outstanding, a workforce of about 1,454 people, and enterprise value near 280.4 M.Profitability
Profitability metrics test whether DocMorris AG is building real earning power or just reporting one-time accounting gains. The key question is whether current profitability is lasting, cyclical, or boosted by items that may not repeat.
The company has Profit Margin (PM) of -11.0 %, which may signal that the company faces structural margin pressure. This is in negative territory, trailing industry peers. Similarly, it shows Operating Margin (OM) of -10.0 %, which indicates that for every 100 dollars of sales, the company generates an operating loss of $10.0. | Last Reported | End Of Year Estimate | ||
| Return On Tangible Assets | -0.39 | -0.37 | |
| Return On Capital Employed | -0.18 | -0.17 | |
| Return On Assets | -0.12 | -0.14 | |
| Return On Equity | -0.33 | -0.31 |
Management Efficiency
The company has return on total asset (ROA) of -7.7 % which suggests that asset utilization is not generating returns above cost. This is in negative territory, trailing industry peers. Similarly, it shows a return on equity (ROE) of -27.47 %, which suggests that shareholder capital is being eroded rather than compounded.| Last Reported | End Of Year Estimate | ||
| Book Value Per Share | 12.78 | 14.48 | |
| Tangible Book Value Per Share | -7.42 | -7.05 | |
| Enterprise Value Over EBITDA | -16.91 | -17.75 | |
| Price Book Value Ratio | 1.62 | 1.54 | |
| Enterprise Value Multiple | -16.91 | -17.75 | |
| Price Fair Value | 1.62 | 1.54 | |
| Enterprise Value | 625.8 M | 594.5 M |
A leadership review of DocMorris AG should test whether management is creating repeatable operating progress instead of relying on one-time gains or favorable cycle conditions. The practical question is whether leadership is improving the economics of the business in ways that can persist once the operating environment gets harder.
Operating Margin | Long Term Debt Total | Operating Margin | Profit Margin | Short Long Term Debt Total |
Technical Drivers
As of the 20th of March, DocMorris lists a market price of 4.09 per share. Market-based metrics show Coefficient Of Variation of -1,077, mean deviation of 2.77, and Standard Deviation of 4.04. Structured modeling of historical data supports trend assessment. Current readings are analyzed relative to broader market benchmarks.DocMorris AG Price Movement Analysis
This analysis covers thirty-two data points across the selected time horizon.
Outstanding Bonds
Corporate bonds issued by DocMorris AG matter because they shape interest expense, maturity risk, and the flexibility management has during tighter credit conditions. Maturity profile, refinancing windows, and coupon burden can all affect how resilient the capital structure looks in a weaker market.
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Predictive Daily Indicators
Daily signals in DocMorris AG help active traders track momentum, reversals, and volume pressure during the session. Used carefully, they can improve execution without tempting investors to overtrade every small swing.
| Accumulation Distribution | 12442.47 | |||
| Daily Balance Of Power | 0.4211 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 4.11 | |||
| Day Typical Price | 4.1 | |||
| Price Action Indicator | 0.025 | |||
| Period Momentum Indicator | 0.08 |
Forecast Models
Forecast models for DocMorris AG use past prices and returns to estimate how the stock may behave under similar conditions. They work best when compared with volatility and catalyst risk rather than treated as a single price target.Debt to Cash Allocation
Tracking debt and cash allocation over time can show when DocMorris is prioritizing expansion, refinancing, or capital return.
DocMorris AG has accumulated CHF312.21 M in total debt. Debt can assist DocMorris until it has trouble settling it off, either with new capital or with free cash flow. So, DocMorris' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DocMorris AG sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DocMorris to invest in growth at high rates of return. When we think about DocMorris' use of debt, we should always consider it together with cash and equity.Total Assets Over Time
Assets Financed by Debt
The debt-to-assets ratio shows the degree to which DocMorris uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.DocMorris Debt Ratio | 22.0 |
Corporate Bonds Issued
DocMorris Short Long Term Debt Total
Short Long Term Debt Total | 217.35 Million |
Stock Analysis Methodology
As a micro-cap equity, DocMorris diagnostic covers margin trends, balance sheet ratios, and price signals. DocMorris trades at P/B of 0.42, P/S of 0.18. Profitability metrics show ROE of -27.47%, net margin of -11.38%, operating margin of -9.81%. Financial distress probability is estimated at 61%. A beta of 0.2112 indicates low sensitivity to broad market moves. A Sharpe ratio of -0.1102 shows market returns below the risk-free rate over the measurement period.
This section for DocMorris AG is built from periodic company reporting and market reference feeds, with harmonization applied to align reporting definitions. Values may update on different source schedules.
This content is curated and reviewed by:
Rifka Kats - Member of Macroaxis Editorial BoardBe your own money manager
Investors considering DocMorris AG as part of a broader investment plan should test whether the position improves portfolio quality without taking on avoidable risk. The better workflow asks how much value the position adds to the whole portfolio, not just what it might do on its own.
Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
| All Next | Launch Module |
Additional Tools for DocMorris Stock Analysis
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |